GB2012168A - Prostaglandin compositions - Google Patents

Prostaglandin compositions

Info

Publication number
GB2012168A
GB2012168A GB791192A GB7901192A GB2012168A GB 2012168 A GB2012168 A GB 2012168A GB 791192 A GB791192 A GB 791192A GB 7901192 A GB7901192 A GB 7901192A GB 2012168 A GB2012168 A GB 2012168A
Authority
GB
United Kingdom
Prior art keywords
prostaglandin
prostaglandin compositions
compositions
triglyceride
composition comprises
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
GB791192A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sandoz AG
Original Assignee
Sandoz AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz AG filed Critical Sandoz AG
Publication of GB2012168A publication Critical patent/GB2012168A/en
Withdrawn legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C405/00Compounds containing a five-membered ring having two side-chains in ortho position to each other, and having oxygen atoms directly attached to the ring in ortho position to one of the side-chains, one side-chain containing, not directly attached to the ring, a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, and the other side-chain having oxygen atoms attached in gamma-position to the ring, e.g. prostaglandins ; Analogues or derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/557Eicosanoids, e.g. leukotrienes or prostaglandins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Inorganic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
GB791192A 1978-01-17 1979-01-12 Prostaglandin compositions Withdrawn GB2012168A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH46378 1978-01-17

Publications (1)

Publication Number Publication Date
GB2012168A true GB2012168A (en) 1979-07-25

Family

ID=4187587

Family Applications (1)

Application Number Title Priority Date Filing Date
GB791192A Withdrawn GB2012168A (en) 1978-01-17 1979-01-12 Prostaglandin compositions

Country Status (20)

Country Link
JP (1) JPS54110313A (US06262066-20010717-C00315.png)
AR (1) AR218518A1 (US06262066-20010717-C00315.png)
AU (1) AU4337979A (US06262066-20010717-C00315.png)
BE (1) BE873481A (US06262066-20010717-C00315.png)
DD (1) DD141260A5 (US06262066-20010717-C00315.png)
DE (1) DE2900428A1 (US06262066-20010717-C00315.png)
DK (1) DK7679A (US06262066-20010717-C00315.png)
ES (1) ES476857A1 (US06262066-20010717-C00315.png)
FI (1) FI790043A (US06262066-20010717-C00315.png)
FR (1) FR2414336A1 (US06262066-20010717-C00315.png)
GB (1) GB2012168A (US06262066-20010717-C00315.png)
GR (1) GR72910B (US06262066-20010717-C00315.png)
IL (1) IL56435A0 (US06262066-20010717-C00315.png)
IT (1) IT7947665A0 (US06262066-20010717-C00315.png)
NL (1) NL7900255A (US06262066-20010717-C00315.png)
NO (1) NO790059L (US06262066-20010717-C00315.png)
NZ (1) NZ189380A (US06262066-20010717-C00315.png)
PT (1) PT69073A (US06262066-20010717-C00315.png)
SE (1) SE7900124L (US06262066-20010717-C00315.png)
ZA (1) ZA79199B (US06262066-20010717-C00315.png)

Cited By (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016610A2 (en) * 1979-03-19 1980-10-01 American Cyanamid Company Method for preserving an E-type prostaglandin and stabilized PGE-type in triethyl citrate solution
EP0049852A2 (de) * 1980-10-09 1982-04-21 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pharmazeutisches Präparat und seine Herstellung
FR2521008A1 (fr) * 1982-02-05 1983-08-12 Sandoz Sa Nouvelles compositions pharmaceutiques a base de thioridazine
EP0093380A2 (en) * 1982-05-03 1983-11-09 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
AU591138B2 (en) * 1985-06-17 1989-11-30 Teijin Limited Fat emulsion of prostaglandin i2
US20140148424A1 (en) * 2007-08-21 2014-05-29 Civitas Therapeutics, Inc. Pulmonary Pharmaceutical Formulations

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3024676A (en) * 1958-11-28 1962-03-13 Sack Gmbh Maschf Hydraulic presses
JPS60116628A (ja) * 1983-11-29 1985-06-24 Teijin Ltd 7−チアプロスタグランジンe↓1類製剤用組成物
JPS60169430A (ja) * 1984-02-14 1985-09-02 Teijin Ltd プロスタグランジン類製剤用組成物
JPS6191136A (ja) * 1984-10-09 1986-05-09 Teijin Ltd プロスタグランジン類製剤用組成物
JPH04342530A (ja) * 1991-04-26 1992-11-30 Teijin Ltd 7−フルオロプロスタサイクリン類脂肪乳剤

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0016610A2 (en) * 1979-03-19 1980-10-01 American Cyanamid Company Method for preserving an E-type prostaglandin and stabilized PGE-type in triethyl citrate solution
EP0016610A3 (en) * 1979-03-19 1981-08-05 American Cyanamid Company Method for preserving an e-type prostaglandin and stabilized pge-type in triethyl citrate solution
EP0049852A2 (de) * 1980-10-09 1982-04-21 F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft Pharmazeutisches Präparat und seine Herstellung
EP0049852A3 (en) * 1980-10-09 1983-01-26 F. Hoffmann-La Roche & Co. Aktiengesellschaft Pharmaceutical formulation and its preparation
FR2521008A1 (fr) * 1982-02-05 1983-08-12 Sandoz Sa Nouvelles compositions pharmaceutiques a base de thioridazine
EP0093380A2 (en) * 1982-05-03 1983-11-09 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
EP0093380A3 (en) * 1982-05-03 1984-03-28 The Trustees Of Columbia University In The City Of New York Use of eicosanoids and their derivatives for treatment of ocular hypertension and glaucoma
AU591138B2 (en) * 1985-06-17 1989-11-30 Teijin Limited Fat emulsion of prostaglandin i2
US5124352A (en) * 1985-06-17 1992-06-23 Teijin Limited Fat emulsions containing isocarbacyclin
US20140148424A1 (en) * 2007-08-21 2014-05-29 Civitas Therapeutics, Inc. Pulmonary Pharmaceutical Formulations

Also Published As

Publication number Publication date
ES476857A1 (es) 1979-05-16
AU4337979A (en) 1979-07-26
IT7947665A0 (it) 1979-01-17
AR218518A1 (es) 1980-06-13
IL56435A0 (en) 1979-03-12
NZ189380A (en) 1981-01-23
SE7900124L (sv) 1979-07-18
FI790043A (fi) 1979-07-18
BE873481A (fr) 1979-07-16
FR2414336A1 (fr) 1979-08-10
GR72910B (US06262066-20010717-C00315.png) 1984-01-04
DE2900428A1 (de) 1979-07-19
ZA79199B (en) 1980-08-27
NO790059L (no) 1979-07-18
DD141260A5 (de) 1980-04-23
DK7679A (da) 1979-07-18
NL7900255A (nl) 1979-07-19
JPS54110313A (en) 1979-08-29
FR2414336B1 (US06262066-20010717-C00315.png) 1981-07-31
PT69073A (fr) 1979-02-01

Similar Documents

Publication Publication Date Title
AU520383B2 (en) Deodorizing composition for ash trays
AU5383979A (en) Surfactant composition
AU528892B2 (en) Polymer-polyol compositions
ZA791554B (en) Low irritating detergent compositions
AU520439B2 (en) Modified organopolysiloxane compositions
PL234834A1 (US06262066-20010717-C00315.png)
GB2012168A (en) Prostaglandin compositions
AU1698076A (en) Nandrolone 17 beta ester compositions
AU4731979A (en) Turbofan thrust vectoring
AU521250B2 (en) Curable organopolysiloxane compositions
AU523002B2 (en) Coal spray composition
AU532040B2 (en) Curable compositions
AU529332B2 (en) Heat-curable organopolysiloxane compositions
GB2011918B (en) Unsaturated curable polyester composition
AU532328B2 (en) Lubricating composition having self releasing properties
AU5364679A (en) Polyarylene ester compositions
AU4376179A (en) Grease composition
JPS5516080A (en) Lubricant composition
JPS5521490A (en) Lubricant composition
GB2040973B (en) Polyester-polyarylene ester compositions
GB2016464B (en) Phenoxyphenoxy unsaturated derivatives and herbicidal compositions thereof
AU525249B2 (en) Oil compositions
JPS5569695A (en) Lubricant composition
AU5056279A (en) Organopolysiloxane composition
AU4610079A (en) Alkaline detergent composition

Legal Events

Date Code Title Description
WAP Application withdrawn, taken to be withdrawn or refused ** after publication under section 16(1)